Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Plaque, Atherosclerotic: later-stage trial registry
1 of 3 indexed Plaque, Atherosclerotic trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Plaque, Atherosclerotic: 3 US clinical trials tracked, 1 recruiting.
Plaque, Atherosclerotic is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is NewAmsterdam Pharma, running 1 of these trials.
Enrollment posture brief
Registry condition plaque-atherosclerotic
OPEN 1 | RECR 33% | LATE 2 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Plaque, Atherosclerotic lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Plaque, Atherosclerotic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Plaque, Atherosclerotic is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
NewAmsterdam Pharma
NCT06305559
Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk
University of North Carolina, Chapel Hill
NCT04063709
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
Boston Scientific Corporation
NCT03064126
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Plaque, Atherosclerotic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Plaque, Atherosclerotic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Plaque, Atherosclerotic page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Plaque, Atherosclerotic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NewAmsterdam Pharma sponsors the most Plaque, Atherosclerotic trials on record, review their full trial history before evaluating a specific study. See NewAmsterdam Pharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Plaque, Atherosclerotic condition card totals 3 registered trials; most-linked intervention Standard Balloon Angioplasty; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.